Background/Aims: Allograft inflammatory factor-1 (AIF-1) is an inflammatory cytokine produced mainly by macrophages within human white adipose tissue. Its expression is increased in obese subjects and positively correlated with insulin resistance. The purpose of this study is to characterize the regulatory role of AIF-1 in insulin signaling of adipocyte. Methods: AIF-1 was over-expressed via transfection of AIF-1 cDNA into murine RAW 264.7 macrophages, and the constitutive expression of AIF-1 was decreased via transfection of targeting siRNA. Murine 3T3L1 adipocytes were treated with macrophage-conditioned medium or AIF-1 protein. Intracellular lipid accumulation was assayed by oil red O stain. Reactive oxygen species production was determinated by a flow cytometer and adipokine secretion was measured with ELISA. Glucose uptake was detected using the glucose oxidase method and insulinsignal-transduction related molecules were analyzed by Western blot. Results: Short term (48 h) AIF-1 treatment slightly promoted intracellular lipid storage in differentiating 3T3L1 cells. The protein stimulated reactive oxygen species production, provoked TNFα, IL6, resistin, but suppressed adiponectin release and insulin-stimulated glucose uptake both under normal basal and insulin resistance conditions. Furthermore, AIF-1 induced NF-κB activation, inhibited PPARγ expression, GLUT4 translocation to plasma membrane and Akt phosphorylation. Conclusion: Macrophage-derived AIF-1 up-regulated reactive oxygen species production, adipokine TNFα, IL6, resistin release, and inhibited adiponectin secretion. Moreover, it suppressed insulin-stimulated glucose uptake by down-regulating insulin signaling. Thus, AIF-1 could be related to obesity-related diseases.
Introduction
Obesity is a major risk factor for the development of insulin resistance, and the progression of diabetes, cardiovascular disease, and other comorbidities [1] . It is considered as a state of chronic low-grade systemic inflammation due to infiltration of activated macrophages in adipose tissue [2, 3] . Numerous studies have stressed that chronic inflammation link excess fat to metabolic disorders [3, 4] . Adipose tissue macrophages produce a number of pro-inflammatory cytokines that significantly alter adipocyte function, inducing lipid accumulation [5] , inflammatory responses [6] and decreasing insulin sensitivity [7] . Identification of the major factors that mediate detrimental effects of adipocyte may offer potential therapeutic targets.
Allograft inflammatory factor-1 (AIF-1) is a calcium-binding inflammation related scaffold protein mainly produced by immune cells [8] . It was firstly identified in activated macrophages in rat cardiac allografts with chronic rejection (GenBank accession number U17919) [9] . Several other molecules such as daintain [10] , ionized Ca 2+ -binding adapter (Iba1) [11] and microglia response factor 1 (MRF-1) [12] are homologues of AIF-1. AIF-1 has been recognized as a crucial molecular for the survival and pro-inflammatory activity of macrophages [13, 14] . Thus, it is involved in inflammation and immune responses associated with vasculopathy [15] , autoimmune diseases [16] , and central nervous system (CNS) injury [17] et al.
Recently, several reports indicated the involvement of AIF-1 in obesity. First, a single nucleotide polymorphism in the AIF-1 gene region was related to body weight [18] . Second, AIF-1 −/− mice were protected from diet induced obesity [19] . Third, AIF-1 was suggested as a novel adipokine produced mainly by macrophages within human white adipose tissue. Its expression was increased in obese subjects and positively correlated with insulin resistance [20] . Based on these findings, the role of AIF-1 in macrophage-induced signaling sensitivity of adipocytes was investigated in the present study using murine RAW264.7 macrophages and 3T3L1 adipocytes.
Materials and Methods

Vector construction and transfection
The pcDNA3.1-AIF1 plasmid was constructed by subcloning the cDNA of murine AIF-1 (GenBank accession number: AB013745.1) into pcDNA3.1(+) at the sites of BamH1 and Xho1 (underlined sequences) with primers: sense, 5′-CGGGATCCGCCACCATGAGCCAAAG -3′ and antisense, 5′-CCGCTCGAGTCAGGGCAGCTCGGAG-3′. Insertion of cDNA was verified by DNA sequencing. In addition, three short interference RNAs (siRNAs) for AIF-1 were synthesized targeted (sequence 1, GCCTTCAAGGTGAAGTACA, siAIF1-1; sequence 2, CCTAGAGCTGAAGAGATTA, siAIF1-2; or sequence 3, CCATCTTGAGAATGATTCT, siAIF1-3) with negative control (target sequence: TTCTCCGAACGTGTCACGT, siRNA) and interference RNA for GAPDH (target sequence: CACTCAAGATTGTCAGCAA, GAPDH420). A murine macrophage cell line, RAW264.7, was obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were activated by lipopolysaccharide and cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco, NY, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 U/mL streptomycin at 37°C in the humidified atmosphere of 5% CO 2 . Then, the cell culture medium was replaced to serum-free DMEM and transfection was performed with a Sofast (Xiamen, Fujian, China) according to the manufacturer's instructions. 48 h later, the medium was harvested by centrifuging at 350 g for 10 min, and filtered through a 0.22 μm filter.
Oil Red O assay
Murine 3T3L1 pre-adipocytes were also obtained from ATCC and grown in DMEM with 10% FBS and 1% penicillin/streptomycin at 37 °C in the humidified atmosphere of 5% CO 2 . The pre-adipocytes were differentiated into adipocytes as we previously described [21] . Briefly, 2 days after confluence (day 0), cells were induced to differentiate by DMEM supplemented with 10% FBS, 0.5 mmol/L 3-isobutyl-1-methyl-xanthine, 0.25 μmol/L dexamethasone and 10 μg/mL insulin (MDI, Sigma, St. Louis, MO, USA) for another 2 days. On the 4 th day, cells were transferred into macrophage-conditioned medium and 10 μg/mL insulin for two more days. Intracellular lipid accumulation of 3T3L1 adipocytes was monitored by the visual appearance of fat droplets in the cells and oil red O stain. The integrated optical density (IOD) of the lipid droplets was used to quantify the lipid accumulation [22] . Measurement of reactive oxygen species and adipokine release Murine 3T3L1 pre-adipocytes were fully differentiated into adipocytes using a standard protocol [21] . Specifically, 2 days after the cells reached confluence, they were incubated in the differentiation medium (DMEM supplemented with 10% FBS and adipogenic cocktail MDI) for 2 days. Then, the cells were maintained in DMEM containing 10% FBS and 10 μg/mL insulin for another 2 days, and replenished with DMEM containing 10% FBS until full differentiation into adipocytes. Thereafter, the medium was replaced with macrophageconditioned medium or 0, 0.1, 1, 10 nmol/L AIF-1 [16] in DMEM supplemented with 10% FBS for 2 days. The cells were harvested by centrifuging at 500 g for 5 min and lysed. The reactive oxygen species production in 3T3L1 adipocytes was measured with cellular reactive oxygen species detection assay kit (Sigma, St. Louis, MO, USA), and analyzed by a flow cytometer (Beckman Coulter FC500, Brea, CA). The secretion concentrations of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL6), resistin and adiponectin from adipocytes and the basal levels of TNFα, IL6 in macrophage-conditioned medium were determined using the corresponding ELISA kits (R&D Systems, Abingdon, UK).
Glucose consumption
Glucose consumption was examined as previously described [23] . Differentiated 3T3L1 adipocytes were exposed for 18 h to DMEM containing 10% FBS and either 5 mmol/L or 25 mmol/L glucose, with or without 0.6 nmol/L insulin, as indicated. Then, the cells were incubated in macrophage-conditioned medium or 0, 0.1, 1, 10 nmol/L AIF-1 in DMEM with 10% FBS for 48 h. Before assay, the cells were stimulated with 100 nmol/L insulin for 30 min and the concentration of glucose in the culture medium was analyzed using the glucose oxidase method.
Western blot
Western blot was employed to detect the expression levels of AIF-1 in RAW264.7 cells at the 48 th h after transfection and to measure nuclear factor kappa B (NF-κB) p65, AKT phosphorylation, peroxisome proliferator-activated receptor-γ (PPARγ) expression, and insulin-responsive glucose transporter 4 (GLUT 4) translocation in differentiated 3T3L1 adipocytes after macrophage-conditioned medium or AIF-1 protein treatment. Total cellular proteins were prepared with lysis buffer containing protease and phosphatase inhibitors (Sigma, St. Louis, MO, USA). The membrane proteins were isolated and extracted with a plasma membrane protein extraction kit (No. PAB180006, Bioswamp, China). Briefly, 5×10 7 3T3L1 adipocytes were washed, re-suspended and homogenized in RIPA lysis buffer containing protease and phosphatase inhibitors with a mortar and pestle. Then the resulting homogenates were centrifuged at 14 000 g for 30 min at 4 °C. After the supernatant was removed, the pellets (membrane debris) were repeatedly homogenized and extensively washed to eliminate the soluble components. Thereafter, the membrane pellets were lysed with solution B in the kit and intermittently oscillated with a vortex oscillator for 30 min at 4 °C, then centrifuged at 14, 000 g for 5 min at 4 °C. The supernatant was the extracted plasma membrane proteins. Protein concentrations were determined using a Pierce™ BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA). The proteins were separated on SDS-PAGE, and transferred to nitrocellulose membranes (Whatman, London, UK). Then the membranes were blocked with TBST (20 mmol/L Tris-HCl, pH 7.6, 0.14 mol/L NaCl, 0.1% Tween 20) containing 5% w/v bovine serum albumin for 1 h at room temperature. After that, the membranes were incubated overnight at 4 °C with the specific primary antibodies against AIF-1 (1:2000, Sanying, Wuhan, China), NF-κB p65 (1:1000, abcam, Cambridge, MA, USA), p-NF-κB p65 (phospho S536, 1:1000, abcam, Cambridge, MA, USA), GLUT 4 (1:1000, abcam, Cambridge, MA, USA), AKT (1:1000, abcam, Cambridge, MA, USA), p-AKT (phospho S473, 1:1000, abcam, Cambridge, MA, USA), GAPDH (1:1000, Sanying, Wuhan, China). Membranes were washed with TBST thoroughly before the corresponding horseradish peroxidase (HRP)-conjugated secondary antibodies were treated. Specific immune complexes were detected by chemiluminescence (West Pico kit, Pierce, Loughborough, UK) and scanned using ChemiDoc™ XRS + (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Data were expressed as means ± standard error of the mean (SEM). Data were analyzed statistically using SPSS Statistics V17.0 software and the significance of the differences between the corresponding groups was determined by ANOVA followed by one tailed multiple t-tests. Value of P < 0.05 was considered as statistical significance. 
Results
AIF-1 over-expression and interference
Lorente-Cebrián and colleagues reported that AIF-1 was secreted in a time dependent manner from white adipose tissue and the major source of AIF-1 was white adipose tissue resident macrophages [20] . In order to investigate the role of AIF-1 in obesity, the level of RAW264.7 cells were tranfected with: siRNA, negative control (target sequence TTCTCCGAACGTGT-CACGT); GAPDH420: interference RNA for GAPDH (target sequence CACTCAAGATTGTCAGCAA); si-AIF1-1, short interference RNA (target sequence GCCTTCAAGGTGAAGTACA); siAIF1-2, short interference RNA (target sequence CCTAGAGCTGAAGA-GATTA); siAIF1-3, short interference RNA (target sequence CCATCTTGAGAATGATTCT); pcDNA3.1, plasmid pcDNA3.1; pcDNA3.1-AIF1, plasmid pcD-NA3.1 subcloned with the cDNA of murine AIF-1(GenBank accession number: AB013745.1). B. The level of AIF-1 expression in RAW264.7 macrophage cells. The level of AIF-1 in siAIF1-2 was significantly lower than that in siRNA, the level of AIF-1 in pcDNA3.1-AIF1 was significantly higher than that in pcDNA3.1. Data were the mean ± SEM of three independent experiments. (**P<0.01).
1 Cell
AIF-1 expression was up-regulated via transfection of the gene into RAW264.7 (pcDNA3.1-AIF1 in Fig. 1 ), and decreased via transfection of siRNA against AIF-1(siAIF1-1, siAIF1-2 and siAIF1-3 in Fig. 1 ). The level of AIF-1 in siAIF1-2 was significantly lower than that in siRNA, the level of AIF-1 in pcDNA3.1-AIF1 was significantly higher than that in pcDNA3.1.Therefore, the serum free DMEM media of RAW264.7 macrophage in pcDNA3.1, pcDNA3.1-AIF1, siRNA and siAIF1-2 were harvested for the following experiment.
Oil red O assay
After 3T3-L1 pre-adipocytes were induced with MDI, they were incubated in macrophage-conditioned medium supplemented with 10% FBS for 2 days and intracellular triglyceride accumulation was monitored by oil red O stain as shown in 
Reactive oxygen species production and adipokine secretion
In addition, the effect of macrophageconditioned medium on reactive oxygen species production, TNFα, IL6, resistin and adiponectin secretion was assayed. The results revealed that AIF-1 upregulation increased TNFα (1.26±0.01 fold, P <0.001, Fig. 3A) , IL6 (1.45±0.01 fold, P <0.001, Fig. 3B ), resistin (1.52±0.02 fold, P <0.001, Fig. 3C ) release and reactive oxygen species production (1.65±0.09 fold, P <0.01, Fig. 3E ), while decreased adiponectin secretion (0.69 ±0.01 fold, P <0.001, Fig. 3D ). At the same time, AIF-1 interference inhibited TNFα (0.84±0.01 fold, P <0.001, Fig. 3A) , IL6 (0.79±0.02 fold, P <0.001, Fig. 3B ), resistin (0.84±0.01 fold, P <0.001, Fig. 3C ) release and reactive oxygen species production (0.88±0.12 fold, Fig.  3E ), but promoted adiponectin secretion (1.24 ±0.02 fold, P <0.001, Fig. 3D ). In line with this, Fig. 3 . Reactive oxygen species production and adipokine release in 3T3L1 adipocytes. 3T3L1 adipocytes were treated with macrophage-conditioned medium (A, B, C, D, E) or 0, 0.1, 1, 10 nmol/L AIF-1 in DMEM (F, G, H, I, J) supplemented with 10% fetal bovine serum for 2 days. The reactive oxygen species production in 3T3L1 adipocytes was measured with cellular reactive oxygen species detection assay kit. The secretion concentrations of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL6), resistin and adiponectin from adipocytes were determined using the corresponding ELI-SA kits. Data were the mean ± SEM of three independent experiments. (*P< 0.05, **P<0.01, ***P<0.001).
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AIF-1 protein also up-regulated TNFα (Fig. 3F) , IL6 (Fig. 3G) , resistin ( Fig. 3H ) release, reactive oxygen species production (Fig. 3J ), but down-regulated adiponectin (Fig. 3I ) secretion in a dose-dependent manner at concentrations of 0.1, 1 and 10 nmol/L. Thus, AIF-1 potently stimulated reactive oxygen species production, inflammatory factors TNFα, IL6 secretion, provoked resistin, but suppressed adiponectin release.
The effect of AIF-1 on PPARγ expression and NF-κB phosphorylation
To investigate the underlying mechanism of AIF-1 inducing inflammatory pathways, the expression of PPARγ and the phosphorylation of NF-κB were analyzed by Western blot. As shown in Fig. 4 , AIF-1 over-expression inhibited PPARγ expression (0.64± 0.01 fold, P <0.001, Fig. 4B ), stimulated NF-κB phosphorylation(1.60± 0.01 fold, P <0.001, Fig. 4C ). But siAIF1-2 increased PPARγ expression (1.91± 0.02 fold, P <0.001, Fig. 4B ), suppressed NF-κB activation (0.43± 0.02 fold, P <0.001, Fig. 4C ). Agree with this, AIF-1 protein down-regulated PPARγ expression to 0.85±0.03 fold, P <0.05 at concentration of 0.1 nmol/L, 0.57±0.04 fold, P <0.01 at concentration of 1 nmol/L and 0.35±0.07 fold, P <0.001 at concentration of 10 nmol/L (Fig. 4E) . It activated NF-κB to 1.31±0.03 fold, P <0.01 at concentration of 0.1 nmol/L, 1.89±0.02 fold, P <0.001 at concentration of 1 nmol/L, 2.13±0.04 fold, P <0.001 at Before assay, the cells were stimulated with 100 nmol/L insulin for 30 min and the concentration of glucose in the culture medium was analyzed using the glucose oxidase method. Data were the mean ± SEM of three independent experiments. (**P<0.01, ***P<0.001). 
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AIF-1 mediates alteration of glucose consumption
In addition, AIF-1 up-regulation led to a reduction in glucose consumption (4. 86±0.16 mmol/L remained vs 3.62±0.15 mmol/L remained in medium of normal pcDNA3.1 adipocytes and 5. 21±0.16 mmol/L remained vs 4.15±0.08 mmol/L remained in medium of adipocytes with insulin resistance, P < 0.001, Fig. 5A ). While this effect was abolished by AIF-1 inhibition (2. 27±0.25 mmol/L remained vs 3.64±0.48 mmol/L remained in medium of normal pcDNA3.1 adipocytes, P < 0.001, and 3.30±0.16 mmol/L remained vs 4.30±0.25 mmol/L remained in medium of adipocytes with insulin resistance, P < 0.01, Fig. 5A ). In accordance with this, AIF-1 protein also suppressed glucose uptake into 3T3L1 adipocytes 
Influence of AIF-1 on GLUT 4 tranlocation and Akt phosphorylation
In the present study, AIF-1 over-expression reduced the content of GLUT 4 on the plasma membrane (0.35±0.01 fold in normal adipocytes, P <0.01; and 0.21±0.01 fold in adipocytes with insulin resistance, P < 0.001, Fig. 6B ), while AIF-1 interference enhanced GLUT 4 translocation to the plasma membrane (1.21±0.02 fold in normal adipocytes, P <0.05; and 2.19±0.03 fold in adipocytes 
Discussion
Obesity is associated with macrophage accumulation in adipose tissue [3] . The macrophage-adipocyte crosstalk in obesity affects adipose tissue biology, but the molecular mechanisms and the key mediators remain largely unknown. In the present study, we investigated the effect of macrophage-derived AIF-1 on lipid storage, inflammatory responses and insulin sensitivity in adipocytes using two macrophage cell lines. One over-expressed AIF-1 via transfection of AIF-1 gene into RAW 264.7 cells, and the other decreased the constitutive expression of AIF-1 via transfection of targeting siRNA. We observed short term AIF-1treatment slightly increased the amount of triglycerides on the 6 th day of differentiation, but cell apoptosis was not affected by AIF-1(data not shown).
Hypertrophied and dysfunctional adipocytes from obese subjects secrete several proinflammatory cytokines such as TNF-α and IL-6. It is well known that TNF-α positively contributes to the inflammatory adipocyte micro-environment, mainly by activating the classic transcription factor NF-κB signaling, the early key event in the pathogenesis of insulin resistance [24, 25] . Furthermore, it may also inhibit PPARγ through activation of NF-κB [26] . Since the GLUT 4 promoter contains response elements for, or regulated by PPARγ [27] , it is likely that TNF-α could suppress GLUT 4 expression via a PPARγ dependent mechanism. On the other hand, elevated IL6 level is also associated with the development of insulin resistance via reduction of GLUT 4, PPARγ and insulin-stimulated glucose uptake in 3T3-L1 adipocytes [28] . Thus, the activation of inflammatory-linked pathways in adipocytes is an important mediator of insulin resistance. In addition, oxidative stress links inflammation to insulin resistance and intracellular reactive oxygen species in adipocytes result in insulin resistance through attenuation of insulin signaling [29] . In this study, AIF-1 induced reactive oxygen species production, TNF-α and IL6 secretion from 3T3L1 adipocytes, further suppressed PPARγ expression and activated NF-κB, which may lead to insulin resistance in adipocytes.
Adiponectin is an adipocyte-secreted polypeptide with a principal role in the suppression of the metabolic derangements that may result in insulin resistance [30] . In contrast to adiponectin, the level of resistin has been shown to be up-regulated in subjects with insulin resistance [31] . The present experiment demonstrated that AIF-1 induced resistin secretion, while deduced adiponectin release from 3T3L1 adipocytes, which also implied the association of AIF-1 with insulin resistance.
LorenteCebrián and colleagues demonstrated AIF-1 was inversely correlated with insulin sensitivity as estimated by insulin tolerance test, and positively correlated with insulin resistance as assayed by homeostasis model assessment for insulin resistance [20] , which inspired us to further investigate the direct inhibitory effect of AIF-1 on the insulin signaling in adipocytes. We observed that AIF-1 indeed reduced insulin-stimulated glucose uptake in 3T3L1 adipocytes both under normal basal and insulin resistance conditions. It is well known that insulin decreases blood glucose levels by promoting glucose uptake into adipose and muscle cells. Under basal conditions, about 95% of GLUT 4 protein is localized within intracellular membrane compartments, with the remaining 5% protein at the cell surface [32] . By contrast, insulin triggers GLUT 4 translocation to the plasma membrane, which results in glucose uptake [33] . It is worthy to note that impaired GLUT 4 translocation Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry to the plasma membrane has been considered as one of the earliest defects leading to insulin resistance and type 2 diabetes [33] . In this study, AIF-1 impaired GLUT 4 translocation to plasma membrane. Next, it suppressed insulin-signal-transduction related molecule Akt phosphorylation. The protein kinase Akt is also known as protein kinase B (PKB). Upon activation, Akt is transported to the plasma membrane where it is phosphorylated at Thr-308 and Ser-473. Thereafter, Akt phosphorylates a range of substrates and the phosphorylation of these substrates orchestrates a complex metabolic program involving binding of insulin to the insulin receptor and the translocation of the glucose transporter GLUT 4 to the plasma membrane leading to glucose uptake [34] .
In conclusion, our data suggest that macrophage-derived AIF-1 stimulated reactive oxygen species production, enhanced adipokine TNFα, IL6, resistin secretion, decreased adiponectin release from 3T3L1 adipocytes probably via inducing NF-κB activation, inhibiting PPARγ expression. Furthermore, it suppressed insulin-stimulated glucose uptake by depressing GLUT 4 translocation to plasma membrane and Akt phosphorylation.
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